Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Buy
69
RVLV Quote, Financials, Valuation and Earnings
Last price:
$22.12
Seasonality move
:
5.76%
Day range:
$22.65 - $23.85
52-week range:
$14.87 - $39.58
Dividend yield:
0%
P/E ratio:
34.07x
P/S ratio:
1.47x
P/B ratio:
3.77x
Volume:
747.3K
Avg. volume:
1.5M
1-year change:
12.75%
Market cap:
$1.7B
Revenue:
$1.1B
EPS (TTM):
$0.68
Analysts' Opinion
-
Consensus RatingRevolve Group has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 6 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $32.00, Revolve Group has an estimated upside of 38.11% from its current price of $23.17.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $19.00 representing 100% downside risk from its current price of $23.17.
Fair Value
-
According to the consensus of 12 analysts, Revolve Group has 38.11% upside to fair value with a price target of $32.00 per share.
RVLV vs. S&P 500
-
Over the past 5 trading days, Revolve Group has overperformed the S&P 500 by 5.13% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Revolve Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Revolve Group has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Revolve Group reported revenues of $293.7M.
Earnings Growth
-
Revolve Group has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Revolve Group reported earnings per share of $0.17.
Enterprise value:
1.4B
EV / Invested capital:
3.18x
Price / LTM sales:
1.47x
EV / EBIT:
27.10x
EV / Revenue:
1.23x
PEG ratio (5yr expected):
0.43x
EV / Free cash flow:
66.22x
Price / Operating cash flow:
78.93x
Enterprise value / EBITDA:
24.63x
Gross Profit (TTM):
$593.3M
Return On Assets:
7.62%
Net Income Margin (TTM):
4.39%
Return On Equity:
12.15%
Return On Invested Capital:
12.15%
Operating Margin:
3.88%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.1B | $1.1B | $1.1B | $257.8M | $293.7M | |
| Gross Profit | $592.3M | $554.2M | $593.3M | $134M | $154.3M | |
| Operating Income | $73.1M | $22.1M | $51.4M | $2.2M | $11.4M | |
| EBITDA | $77.9M | $27.2M | $56.6M | $3.5M | $12.6M | |
| Diluted EPS | $0.79 | $0.38 | $0.68 | $0.05 | $0.17 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $276.9M | $439.8M | $518.2M | $528.6M | $561.1M | |
| Total Assets | $305.8M | $480.4M | $579.3M | $608.9M | $665.5M | |
| Current Liabilities | $105.7M | $160.2M | $181.1M | $189.6M | $196.1M | |
| Total Liabilities | $105.7M | $163.4M | $199.7M | $223.7M | $227.8M | |
| Total Equity | $200.1M | $317M | $379.6M | $385.1M | $437.8M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $23.4M | $43.3M | $26.7M | -$3.9M | $3.9M | |
| Cash From Investing | -$5.2M | -$4.2M | -$9.1M | -$1.1M | -$2.1M | |
| Cash From Financing | $887K | -$30.4M | -$5.4M | -$18.3M | $5.6M | |
| Free Cash Flow | $18.3M | $39.1M | $21M | -$5M | $2.1M | |
RVLV
Sector
Market Cap
$1.7B
$412.6M
Price % of 52-Week High
58.54%
70.4%
Dividend Yield
0%
0%
Shareholder Yield
0.49%
3.85%
1-Year Price Total Return
12.75%
-15%
Beta (5-Year)
2.252
0.943
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$22.61
200-day SMA
Sell
Level
$25.75
Bollinger Bands (100)
Sell
Level
25.85 - 35.11
Chaikin Money Flow
Buy
Level
11.8M
20-day SMA
Sell
Level
$23.44
Relative Strength Index (RSI14)
Sell
Level
41.61
ADX Line
Sell
Level
42.2
Williams %R
Neutral
Level
-48.2301
50-day SMA
Sell
Level
$27.57
MACD (12, 26)
Sell
Level
-1.50
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Neutral
Level
51.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (9.534)
Buy
CA Score
(Annual)
Level (1.2662)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-1.8466)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
The Revolve Group is an emerging e-commerce retailer, selling women’s dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the US, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of unique products from emerging fashion brands with less than $10 million in annual sales.
Stock Forecast FAQ
In the current month, RVLV has received 6 Buy ratings 6 Hold ratings, and 0 Sell ratings. The RVLV average analyst price target in the past 3 months is $32.00.
-
Where Will Revolve Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that Revolve Group share price will rise to $32.00 per share over the next 12 months.
-
What Do Analysts Say About Revolve Group?
Analysts are divided on their view about Revolve Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Revolve Group is a Sell and believe this share price will drop from its current level to $19.00.
-
What Is Revolve Group's Price Target?
The price target for Revolve Group over the next 1-year time period is forecast to be $32.00 according to 12 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is RVLV A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Revolve Group is a Leans Bullish. 6 of 12 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of RVLV?
You can purchase shares of Revolve Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Revolve Group shares.
-
What Is The Revolve Group Share Price Today?
Revolve Group was last trading at $22.12 per share. This represents the most recent stock quote for Revolve Group. Yesterday, Revolve Group closed at $23.17 per share.
-
How To Buy Revolve Group Stock Online?
In order to purchase Revolve Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is down 13.28% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.1% over the past day.
Buy
51
CAR alert for Mar 28
Avis Budget Group [CAR] is down 0.69% over the past day.
